These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9620788)
21. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555 [No Abstract] [Full Text] [Related]
22. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
23. Questions raised about whether compulsory licenses get best prices. Owens B Nat Med; 2015 Apr; 21(4):300. PubMed ID: 25849264 [No Abstract] [Full Text] [Related]
25. An export-only exception to pharmaceutical patents in Europe: should the United States follow suit? Minssen T; Kesselheim AS; Darrow JJ Nat Biotechnol; 2019 Jan; 37(1):21-22. PubMed ID: 30605154 [No Abstract] [Full Text] [Related]
26. "Obvious to try": a proper patentability standard in the pharmaceutical arts? Trask AV Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581 [No Abstract] [Full Text] [Related]
27. The Affordable Prescription Drugs Act: a solution for today's high prescription drug prices. Pinzone JD J Law Health; 2001-2002; 16(1):145-68. PubMed ID: 14650775 [No Abstract] [Full Text] [Related]
28. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro. Resnik DB; DeVille KA Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852 [No Abstract] [Full Text] [Related]
29. Bugs or drugs, tortoises or hares? Jacobs T Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079 [No Abstract] [Full Text] [Related]
30. [Development costs, regulation and audit in the German SHI Drug Sector]. Kamp F; Walter P; Bücheler R Gesundheitswesen; 2014 Jan; 76(1):7-18. PubMed ID: 24446140 [No Abstract] [Full Text] [Related]
31. Biotech R&D still reeling. Lawrence S Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460 [No Abstract] [Full Text] [Related]
32. Congress, the FDA, and the fair development of new medications for children. McKinney RE Pediatrics; 2003 Sep; 112(3 Pt 1):669-70. PubMed ID: 12949299 [No Abstract] [Full Text] [Related]
33. New rules for US drug reimbursement. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382 [No Abstract] [Full Text] [Related]
34. Public biotech in 2014--the numbers. Morrison C; Lähteenmäki R Nat Biotechnol; 2015 Jul; 33(7):703-9. PubMed ID: 26154007 [No Abstract] [Full Text] [Related]